Owlet (NYSE:OWLT) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.24) by 25 percent. The company reported $24.94 million in sales this quarter.
Moderna Bolsters Its Pipeline With Two New mRNA-Based Vaccine Programs
Moderna Inc (NASDAQ:MRNA) expands its mRNA pipeline with two new development programs ahead of Annual Vaccines Day, building on Moderna’s experience…